GLP-1 Weight Loss in Charleston, SC: What It Costs Today, and Why South Carolina Medicaid Just Stopped Covering It
Charleston's obesity rate sits well below South Carolina's, but Medicaid reversed obesity-indication GLP-1 coverage after about 14 months, leaving a published-price cash market.
Charleston's adult obesity rate is 28.7% (CDC PLACES, city-level crude prevalence, BRFSS 2023) 1, 7.3 points below South Carolina's statewide 36.0% (CDC BRFSS, same year) 2. Charleston is healthier than its state and still carries real burden across a city of 159,011 3.
The local hook is not the obesity number, it is the coverage reversal: South Carolina Medicaid stopped paying for GLP-1s for weight loss at the end of 2025, roughly 14 months after it started.
No active GEOGRAPHIC-area HPSA covers Charleston (city or county) for primary care, mental health, or dental health, per HRSA's national HPSA export (refreshed Aug 27, 2026). The only current designations touching the city are FACILITY-type HPSAs for Fetter Health Care Network, Inc., a safety-net FQHC at 51 Nassau St, Charleston, SC 29403 — scored 14 (Primary Care), 21 (Mental Health), 21 (Dental Health), covering a designated population of 154,576. A second FQHC facility HPSA covers St. James Health & Wellness in rural McClellanville, outside city limits. Several historical geographic designations ("Low Income - Charleston," "Low Income - Sea Islands," "Low Income - North Charleston") were withdrawn and are no longer active. Read: Charleston is not an officially designated shortage area at large — the documented gap is concentrated among low-income/uninsured patients served by the FQHC network, not the general population.6
Specialist access
Charleston is anchored by the Medical University of South Carolina (MUSC), which has run a dedicated Weight Management Center since 1974 and operates endocrinology clinics inside city limits (West Ashley Medical Pavilion, Rutledge Tower downtown) plus one just across the North Charleston line. That gives Charleston materially stronger in-person specialist/endocrinology infrastructure than most tier-2 metros — specialist access is not the core local barrier. The one documented gap is narrower: HRSA's active FQHC-facility HPSA for Fetter Health Care Network signals the shortfall is concentrated among low-income/uninsured patients routed through the safety-net system, not a citywide shortage of endocrinologists or obesity-medicine providers.1617
Medicaid coverage note
South Carolina Medicaid removed GLP-1 medications for the obesity/weight-loss indication from its Preferred Drug List effective 12/31/2025 — coverage for weight loss ends essentially January 1, 2026. Confirmed directly against SC DHHS's own Pharmacy & Therapeutics Committee minutes (Nov. 5, 2025), which state the change was adopted with no changes to coverage for the diabetes indication. Diabetes-indication GLP-1 coverage is unaffected and continues. Supplementary reporting (Index-Journal/States Newsroom) states SC had added the obesity-indication benefit only around November 2024 — as the 14th state to do so — before reversing it about 14 months later, citing cost pressure (state officials cited roughly $2.3M in state spending plus $5.5M in federal spending on obesity-indication prescriptions in the prior fiscal year, against an original ~$3.3M/year combined projection); these supplementary details come from that news report rather than the primary committee record and were not independently re-verified beyond it. Net effect for Charleston: Medicaid enrollees seeking a GLP-1 for weight loss now have no coverage path and must pay cash — through a local clinic or a telehealth provider — or qualify under a diabetes diagnosis.15
South Carolina Medicaid's reversal, dated
South Carolina Medicaid removed GLP-1 medications for the obesity and weight-loss indication from its Preferred Drug List effective 12/31/2025, so coverage for weight loss ends essentially January 1, 2026. That is confirmed directly against SC DHHS's own Pharmacy & Therapeutics Committee minutes of Nov. 5, 2025, which state the change was adopted with no changes to coverage for the diabetes indication 15. Diabetes-indication GLP-1 coverage is unaffected and continues.
Supplementary reporting from Index-Journal and States Newsroom states South Carolina had added the obesity-indication benefit only around November 2024, as the 14th state to do so, before reversing it about 14 months later citing cost pressure, with state officials citing roughly $2.3M in state spending plus $5.5M in federal spending on obesity-indication prescriptions in the prior fiscal year against an original projection of about $3.3M a year combined; those details come from that news report rather than the primary committee record and were not independently re-verified beyond it 14. Net effect for Charleston: Medicaid enrollees seeking a GLP-1 for weight loss now have no coverage path and must pay cash, through a local clinic or a telehealth provider, or qualify under a diabetes diagnosis.
What GLP-1 care costs in Charleston today
Holy City Med in West Ashley, at 2039 Savannah Highway inside Charleston city limits, publishes a dose-tiered sheet: semaglutide $99/month at 0.25 or 0.5mg, $149 at 1.0 to 1.25mg, $199 at 1.5 to 1.75mg, and $249 at 2.0 to 2.5mg; tirzepatide $149 at 2.5mg rising through $249, $349, $449, and $549 to $649 at 15mg. It requires a $40/month program fee, waived for existing members, plus a $49 initial consult, waived for members, and includes provider follow-ups and monthly B12 injections, with $35 shipping per shipment or free pickup at the clinic (checked Aug 28, 2026) 9.
Pearl Medspa Charleston at 601 Meeting St on the downtown peninsula lists semaglutide starting at $225/month and tirzepatide starting at $300/month; this is pearlmedspachs.com, and its Pearl Membership banner is a general spa discount priced separately at $1,000/year or $49.99/month, not GLP-1 pricing 10. Holy City HC runs an at-home concierge model at a flat $250/month including in-home injection administration, monthly 3D body-composition scans, a wellness supplement stack, and RN-led nutrition support, stating it is located in Charleston without publishing a street address 11. Several other named Charleston providers, including Charleston Healthspan Institute and Shine Medical Spa, publish no prices at all, and call-for-pricing is itself the finding 1213.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 per year. It is not a Charleston-specific rate.
Strong specialists, one narrow documented gap
Unlike most tier-2 markets, Charleston is not specialist-constrained. It is anchored by the Medical University of South Carolina, which has run a dedicated Weight Management Center since 1974 and operates endocrinology clinics inside city limits at the West Ashley Medical Pavilion and Rutledge Tower downtown, plus one just across the North Charleston line 1617. That is materially stronger in-person endocrinology infrastructure than most tier-2 metros.
The documented gap is narrower. No active geographic-area HPSA covers Charleston, city or county, for primary care, mental health, or dental health, per HRSA's national HPSA export refreshed Aug 27, 2026. The only current designations touching the city are facility-type HPSAs for Fetter Health Care Network, Inc., a safety-net FQHC at 51 Nassau St, scored 14 for primary care, 21 mental health, and 21 dental, covering a designated population of 154,576; a second FQHC facility HPSA covers St. James Health & Wellness in rural McClellanville outside city limits. Several historical geographic designations, Low Income - Charleston, Low Income - Sea Islands, and Low Income - North Charleston, were withdrawn and are no longer active 678. The shortfall is concentrated among low-income and uninsured patients routed through the safety-net system, not a citywide shortage.
So the honest telehealth case in Charleston is convenience and price transparency rather than access of last resort: a full evaluation and a published flat price without finding and comparing local cash sheets. The South Carolina GLP-1 overview covers statewide policy.
Astra treats patients in South Carolina through state-licensed physicians.
Local options
Holy City Med (West Ashley, Charleston) — Published dose-tiered price sheet — Semaglutide: $99/mo (0.25mg or 0.5mg) → $149/mo (1.0–1.25mg) → $199/mo (1.5–1.75mg) → $249/mo (2.0–2.5mg). Tirzepatide: $149/mo (2.5mg) → $249/mo → $349/mo → $449/mo → $549/mo → $649/mo (15mg). Requires a $40/mo program fee (waived for existing members) plus a $49 initial consult (waived for members); includes provider follow-ups and monthly B12 injections. Shipping is $35/shipment, or free at the clinic. Address: 2039 Savannah Highway, Charleston, SC 29407 — West Ashley, inside Charleston city limits (the practice's other location, 5479 N. Rhett Ave, is in North Charleston, a separate incorporated city). https://www.holycitymed.com/weight-loss(checked 2026-08-28)
Pearl Medspa Charleston (downtown) — Semaglutide prescriptions listed 'starting at $225/month'; Tirzepatide 'starting at $300/month.' Address: 601 Meeting St, Suite 150, Charleston, SC 29403 (downtown peninsula). This is pearlmedspachs.com, the Charleston, SC business — a same-named 'Pearl Medspa' at pearlmedspa.com is an unrelated Portland/Scottsdale chain, do not confuse the two. The 'Pearl Membership' banner referenced on this page is priced on a separate page (pearlmedspachs.com/membership: $1,000/yr or $49.99/mo, a general spa discount) — it is not GLP-1-specific pricing. https://pearlmedspachs.com/services/weight-loss-consultation-in-charleston-sc/(checked 2026-08-28)
Holy City HC (at-home concierge, Charleston) — Flat package price: $250/month, described as including in-home injection administration, monthly 3D body-composition scans, a wellness supplement stack, and RN-led nutrition support. Site states 'Located In Charleston, SC' but publishes no street address (home-visit/concierge model, not a storefront); phone 843-983-2870. https://holycityhc.com/services/semaglutide-ozempic-weight-loss-at-home-in-charleston/(checked 2026-08-28)
Frequently asked questions
Is Astra cheaper than local GLP-1 clinics in Charleston, SC?
Yes, based on the prices Charleston clinics publish. Astra's national price is a flat $68/month for semaglutide and $118/month for tirzepatide on a 12-month plan ($816/$1,416 billed annually) — the same in Charleston as everywhere else Astra operates. Every Charleston provider with a published price starts higher: Holy City Med's own dose-tiered sheet runs $99–$249/month for semaglutide and $149–$649/month for tirzepatide; Pearl Medspa lists semaglutide 'starting at $225/month' and tirzepatide 'starting at $300/month'; Holy City HC's at-home program is a flat $250/month. Several other Charleston providers, including Charleston Healthspan Institute and Shine Medical Spa, don't publish a price at all. One caveat: local packages can bundle extras — in-clinic injections, membership perks, in-person visits — that Astra's price does not include, and clinic prices can change, so always check the current page.
How much does semaglutide or tirzepatide cost in Charleston, SC without insurance?
Prices vary widely and most Charleston clinics don't publish them. Of the providers whose own websites list prices (checked Aug 28, 2026): Holy City Med (West Ashley) charges $99–$249/month for semaglutide and $149–$649/month for tirzepatide depending on dose, plus a $40/month program fee and $49 consult (both waived for members); Pearl Medspa (downtown) lists semaglutide 'starting at $225/month' and tirzepatide 'starting at $300/month'; Holy City HC's at-home concierge program is a flat $250/month. Several other named Charleston providers require a phone call for pricing. Astra's flat national telehealth price is $68/month for semaglutide and $118/month for tirzepatide on a 12-month plan.
Does South Carolina Medicaid still cover semaglutide or tirzepatide for weight loss in 2026?
No. South Carolina Medicaid removed GLP-1 medications from its Preferred Drug List for the obesity/weight-loss indication effective December 31, 2025 (coverage ends essentially January 1, 2026), per SC DHHS's own Pharmacy & Therapeutics Committee meeting minutes. This reverses a policy South Carolina had only added around late 2024. Coverage for GLP-1s prescribed for Type 2 diabetes is unchanged. Charleston Medicaid enrollees seeking a GLP-1 specifically for weight loss now need to pay cash — through a local clinic or a telehealth provider like Astra — or qualify under a diabetes diagnosis.
What is the obesity rate in Charleston, SC compared to the rest of South Carolina?
Charleston's obesity rate is 28.7% (CDC PLACES, city-level crude prevalence, 2023 data), about 7.3 percentage points below South Carolina's statewide rate of 36.0% (CDC BRFSS, same year). Charleston is meaningfully healthier than the state as a whole, though it still carries a substantial obesity burden.
Is Astra available to patients in Charleston, SC?
Yes. Astra is licensed to treat patients in all 50 states, including South Carolina, so Charleston residents can complete a full telehealth evaluation and, if appropriate, get a GLP-1 prescription without needing an in-person visit to a local clinic.